Učitavanje...

Alemtuzumab Induction and Tacrolimus Monotherapy in Pancreas Transplantation: One- and Two-Year Outcomes

BACKGROUND: Alemtuzumab (Campath-1H) induction with tacrolimus monotherapy has been shown to provide effective immunosuppression for kidney, liver, lung, and small bowel transplantation. This drug combination was evaluated in pancreas transplant recipients. METHODS: Sixty consecutive pancreas transp...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Thai, Ngoc L., Khan, Akhtar, Tom, Kusum, Blisard, Deanna, Basu, Amit, Tan, Henkie P., Marcos, Amadeo, Fung, John J., Starzl, Thomas E., Shapiro, Ron
Format: Artigo
Jezik:Inglês
Izdano: 2006
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2952504/
https://ncbi.nlm.nih.gov/pubmed/17198247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.tp.0000250712.12389.3d
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!